Klinikum Würzburg Mitte gGmbH Standort Missioklinik Medizinische Klinik mit Schwerpunkt Pneumologie
- Address
- lock Available on a paid plan
Klinikum Würzburg Mitte gGmbH - Pulmonary Medicine Specialization
The Missioklinik Medical Clinic with a focus on Pneumology is a specialized center within Klinikum Würzburg Mitte gGmbH, dedicated to advancing the understanding and treatment of complex pulmonary disorders. The center participates in cutting-edge clinical research, focusing on innovative therapeutic approaches for serious respiratory and cardiovascular conditions.
- Pulmonary Arterial Hypertension (PAH) treatment trials
- Novel oral inhalation therapies for pulmonary vascular diseases
- Advanced cardiopulmonary exercise capacity assessment
The clinic plays a vital role in evaluating emerging treatments for Pulmonary Arterial Hypertension, participating in Phase 3 randomized controlled trials that assess new therapeutic agents as adjunct therapy to existing disease-specific medications. Their expertise in exercise capacity evaluation and comprehensive patient monitoring positions them as a key contributor to the development of next-generation treatments for patients with severe pulmonary vascular complications.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1GB002 Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikum Würzburg Mitte gGmbH Standort Missioklinik Medizinische Klinik mit Schwerpunkt Pneumologie
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Seralutinib Efficacy and Safety in Pulmonary Arterial Hypertension: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial | GB002 Inc. | Phase III | Not Recruiting | Dec 2023 | Dec 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Seralutinib | 2 | Unknown | 2023-12-14 | 2024-07-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.